Database of patients with lymphoma at Institut Paoli-Calmettes
Institut Paoli Calmettes Breast Cancer Database
This study is creating a database to collect information about lymphoma patients at Institut Paoli-Calmettes to help understand their experiences and improve future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 16000 (estimated) |
| Ages | 18 Years to 95 Years |
| Sex | All |
| Sponsor | Institut Paoli-Calmettes Academic / other |
| Locations | 1 site (Marseille, Bouches-du Rhône) |
| Trial ID | NCT02869542 on ClinicalTrials.gov |
What this trial studies
This observational study involves the creation of a comprehensive database for patients diagnosed with lymphoma at the Institut Paoli-Calmettes. The database aims to collect and analyze clinical data to better understand the characteristics and outcomes of lymphoma patients. By gathering this information, researchers hope to identify trends and improve future treatment approaches for lymphoma. The study does not involve any specific interventions or treatments, focusing solely on data collection.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with Hodgkin or non-Hodgkin lymphoma.
Not a fit: Patients who do not have a diagnosis of lymphoma will not benefit from this study.
Why it matters
Potential benefit: If successful, this database could enhance understanding of lymphoma and lead to improved patient care and treatment strategies.
How similar studies have performed: While this approach is observational and may not have direct treatment implications, similar databases have been successful in enhancing knowledge and treatment of various cancers.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hodgkin or non-hodgkin lymphoma Exclusion Criteria: * Non applicable
Where this trial is running
Marseille, Bouches-du Rhône
- Institut Paoli-Calmettes — Marseille, Bouches-du Rhône, France (Recruiting)
Study contacts
- Study coordinator: Dominique Genre, MD
- Email: drci.up@ipc.unicancer.fr
- Phone: 0033491223778
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.